Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (1y) (2013 - 2026)
Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 46.43% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -436.40% |
| 10 | Zimmer Biomet Holdings | 18.18 Bn | 17.75 Bn | 1.51 Bn | 2.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.70% |
| Dec 31, 2025 | 1.69% |
| Sep 30, 2025 | -6.77% |
| Jun 30, 2025 | -7.19% |
| Mar 31, 2025 | -50.53% |
| Dec 31, 2024 | 10.50% |
| Sep 30, 2024 | -29.17% |
| Jun 30, 2024 | -22.29% |
| Mar 31, 2024 | 48.25% |
| Dec 31, 2023 | -65.74% |
| Sep 30, 2023 | 58.70% |
| Jun 30, 2023 | 21.55% |
| Mar 31, 2023 | 7.22% |
| Dec 31, 2022 | 60.15% |
| Sep 30, 2022 | -5.42% |
| Jun 30, 2022 | 30.26% |
| Mar 31, 2022 | -28.65% |
| Dec 31, 2021 | -4.20% |
| Sep 30, 2021 | -6.83% |
| Jun 30, 2021 | 118.35% |